Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lecithin in Parkinson's disease

A Barbeau

    Journal of Neural Transmission. Supplementum
    |January 1, 1980
    PubMed
    Summary

    Dementia in Parkinson's disease (PD) may resemble Alzheimer's disease, potentially linked to cholinergic deficiency. Lecithin supplementation showed promise in improving cognitive function and reducing toxic symptoms in PD patients with dementia.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Pathogenesis of Parkinson's Disease.

    Canadian Medical Association journal·2010
    Same author

    Beta cell compensation for insulin resistance in Zucker fatty rats: increased lipolysis and fatty acid signalling.

    Diabetologia·2006
    Same author

    [Reactions of social workers in a mental health day center and the avoidance of institutionalization of individual defense mechanisms].

    Sante mentale au Quebec·1992
    Same author

    [Clinical reflections on the setting up of a residence for social reinsertion of schizophrenics].

    Sante mentale au Quebec·1992
    Same author

    Dominantly inherited ataxias in Portugal.

    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·1988
    Same author

    Linkage studies of Friedreich ataxia by means of blood-group and protein markers.

    American journal of human genetics·1987

    Area of Science:

    • Neurology
    • Neuroscience
    • Pharmacology

    Background:

    • Parkinson's disease (PD) dementia, especially after levodopa therapy, shares similarities with Alzheimer's disease.
    • A hypothesis suggests cholinergic deficiency, exacerbated by aging and levodopa's dopaminergic effects, contributes to PD dementia.
    • Neurofibrillary tangles and choline acetyltransferase deficiency are implicated in late-stage PD dementia.

    Purpose of the Study:

    • To investigate the hypothesis that cholinergic deficiency contributes to dementia in Parkinson's disease.
    • To evaluate the efficacy of lecithin supplementation in improving cognitive function and reducing symptoms in PD patients with dementia.

    Main Methods:

    • A study involved 10 levodopa-treated Parkinson's disease patients with dementia receiving an average of 20 grams of lecithin daily.
    • Cognitive function was assessed using the Kohs block design test.
    • An additional study examined lecithin's effect on levodopa-induced abnormal movements.

    Main Results:

    • Lecithin administration led to significant improvement in constructive abilities as measured by the Kohs block design test.
    • Patients experienced a reduction in toxic symptoms, including confusion, hallucinations, and nightmares.
    • Lecithin decreased levodopa-induced abnormal movements but negatively impacted motor performance.

    Conclusions:

    • The findings suggest that the progressive dementia associated with Parkinson's disease may not be irreversible.
    • Lecithin supplementation shows potential as a therapeutic strategy for managing cognitive decline and associated symptoms in PD.
    • Further research is warranted to explore the therapeutic potential of lecithin in Parkinson's disease dementia.

    Related Experiment Videos